Charles M Perou

发表

Improved indel detection in DNA and RNA via realignment with ABRA2

Lisle E Mose, Charles M Perou, Joel S Parker, 2019, Bioinform..

Proper Use of Allele-Specific Expression Improves Statistical Power for cis-eQTL Mapping with RNA-Seq Data

Jung-Ying Tzeng, Wei Sun, Charles M Perou, 2015, Journal of the American Statistical Association.

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Paul Ellis, Nazneen Rahman, Alexander Gutin, 2018, Nature Medicine.

DNA microarrays in breast cancer: the promise of personalised medicine

Sridhar Ramaswamy, Charles M Perou, S. Ramaswamy, 2003, The Lancet.

Tumor mutational burden is a determinant of immune-mediated survival in breast cancer

Guangxu Jin, Michael L. Gatza, Charles M Perou, 2018, Oncoimmunology.

Systems biology and genomics of breast cancer.

Charles M Perou, C. Perou, A. Børresen-Dale, 2011, Cold Spring Harbor perspectives in biology.

CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.

Charles M Perou, Matthew D. Smith, Feng Bai, 2009, Cancer cell.

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.

Zhiyuan Hu, Charles M Perou, Melissa A Troester, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

Zhiyuan Hu, Nicholas P Gauthier, Charles M Perou, 2006, Breast Cancer Research.

Gene expression patterns associated with p53 status in breast cancer

Charles M Perou, Melissa A Troester, Katherine A Hoadley, 2006, BMC Cancer.

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Li Ding, David Fenyö, Jason M Held, 2017, Nature Communications.

A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

Mark T. W. Ebbert, Samuel Leung, Charles M Perou, 2010, Clinical Cancer Research.

Tumor Heterogeneity: Focus on the Leaves, the Trees, or the Forest?

Charles M Perou, Joel S Parker, C. Perou, 2015, Cancer cell.

Microarrays and Epidemiology: Ensuring the Impact and Accessibility of Research Findings

Charles M Perou, Melissa A Troester, C. Perou, 2009, Cancer Epidemiology Biomarkers & Prevention.

αB-crystallin expression in breast cancer is associated with brain metastasis

Charles M Perou, C. Fan, C. Perou, 2015, npj Breast Cancer.

Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues.

Charles M Perou, Steven Bayer, Aniko Szabo, 2007, Clinical chemistry.

FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival

Charles M Perou, Dmitry Turbin, Harikrishna Nakshatri, 2007, Clinical Cancer Research.

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures

Yufeng Liu, Charles M Perou, Joel S Parker, 2011, BMC Medical Genomics.

BMC Genomics BioMed Central Methodology article Universal Reference RNA as a standard for microarray experiments

David Botstein, Alexey Novoradovsky, Charles M Perou, 2004 .

The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas

Charles M Perou, Jason I. Herschkowitz, Xiaping He, 2008, Breast Cancer Research.

Clinical implementation of the intrinsic subtypes of breast cancer.

Charles M Perou, Joel S Parker, Matthew J Ellis, 2010, The Lancet. Oncology.

A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer.

Charles M Perou, Charlotte Kuperwasser, Kristen Anderson, 2009, Cancer research.

Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?

Charles M Perou, Joel S Parker, Lisa A Carey, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.

Li Ding, Joshua F. McMichael, Ron Bose, 2013, Cell reports.

EGFR associated expression profiles vary with breast tumor subtype

Charles M Perou, Melissa A Troester, Katherine A Hoadley, 2007, BMC Genomics.

Evaluating the comparability of gene expression in blood and brain

Charles M Perou, Patrick F Sullivan, C. Fan, 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer

Robert Welch, Charles M Perou, Vessela Kristensen, 2007, International journal of cancer.

A compact VEGF signature associated with distant metastases and poor outcomes

Zhiyuan Hu, Charles M Perou, Olufunmilayo I Olopade, 2009, BMC medicine.

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

Zhiyuan Hu, Charles M Perou, Jason I. Herschkowitz, 2007, Genome Biology.

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.

Anastasia Ivanova, Charles M Perou, Katherine A Hoadley, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models

Charles M Perou, William C Zamboni, Gina Song, 2014, Clinical Cancer Research.

Molecular stratification of triple-negative breast cancers.

Charles M Perou, C. Perou, 2010, The oncologist.

Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study

Zhiyuan Hu, Charles M Perou, Andrew F Olshan, 2018, Journal of the National Cancer Institute.

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

Samuel Leung, Charles M Perou, Steven McKinney, 2008, Clinical Cancer Research.

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

Jane E. Carpenter, Peter Kraft, Gary K. Chen, 2011, Nature Genetics.

PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers

Mark T. W. Ebbert, Charles M Perou, Roy R. L. Bastien, 2012, BMC Medical Genomics.

SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling

Wei Sun, Lisle E Mose, Charles M Perou, 2017, Genome Biology.

Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.

Yiling Lu, Gordon B Mills, Fan Zhang, 2009, Cancer cell.

MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11

Charles M Perou, Dezheng Huo, Olufunmilayo I Olopade, 2013, Nature Communications.

I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms

Donglin Zeng, Dan-Yu Lin, Charles M Perou, 2019, Genome Biology.

Statistical modeling for selecting housekeeper genes

Charles M Perou, Aniko Szabo, C. Perou, 2004, Genome Biology.

The molecular basis of breast cancer pathological phenotypes

Benjamin Haibe-Kains, Andrew H. Beck, David A Gutman, 2017, The Journal of pathology.

A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.

Chad A Shaw, Gordon B Mills, Charles M Perou, 2013, Cancer research.

Assessment of Topoisomerase II (cid:1) Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization

Charles M Perou, Miguel de la Hoya, Xiaping He, 2011 .

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update.

David L Rimm, Charles M Perou, Lisa M McShane, 2020, Archives of pathology & laboratory medicine.

Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas

Charles M Perou, Vessela Kristensen, Stephen J Chanock, 2007, Breast Cancer Research.